Abstract: Motion contrast depth scanning is disclosed herein. A disclosed example apparatus includes an illumination source that is to provide at least one of spatial or temporal changes to light emitted from the illumination source to a scene. The example apparatus also includes a motion contrast sensor, where pixels of the motion contrast sensor are to detect changes corresponding to the scene, and where the motion contrast sensor is to report measurements when a pixel change exceeds a threshold. The example apparatus further includes a processor to determine at least one of a reflectance, a depth, or movement of the scene based on the reported measurements by the motion contrast sensor.
Type:
Grant
Filed:
May 29, 2015
Date of Patent:
May 28, 2019
Assignee:
Northwestern University
Inventors:
Oliver Strider Cossairt, Nathan Matsuda
Abstract: The self-retaining nasal septum retractor includes two pivotally attached arms having handles on one end and speculum blades on the opposing end. The speculum blades are adjustably connected to the arms through pivoting joints. A user can adjust the vertical displacement and angular relation between the speculum blades and the arms to fit different patient septal/nasal structures. A self-retaining mechanism allows a user to lock the retractor in a retracted position, freeing up a hand of the user for other surgical tasks.
Abstract: Variants of phosphotriesterase have been created that exhibit enhanced hydrolysis of V-type and G-type nerve agents over wild-type phosphotriesterase. V- and G-type nerve agents have an SP and RP enantiomer. The SP enantiomers are more toxic. V-type nerve agents are among the most toxic substances known. Variants of phosphotriesterase can prefer to hydrolyze one enantiomer of VX over the other enantiomer.
Abstract: The extract of Vicia faba beans is prepared by soaking beans in distilled water overnight and then boiling in a water bath to reduce the volume of aqueous extract, which is then homogenized and filtered. The filtrate is concentrated to a smaller volume, lyophilized, and powdered. The lyophilized powder is extracted with hexane to remove oils and lipids. The oil-free lyophilized powder is dissolved in ethanol solvent and extracted for eight hours under reflux, and filtered. The volume of ethanol is reduced by a rotary evaporator, and a first off-white precipitate (sample A-1) is collected, washed with ethanol, and dried at 80° C. Mass spectrometry shows a molecular weight of 200.16447 g mol?1, and an empirical formula of C9H16N2O3 is assigned. Intraperitoneal injection of mice with 50 mg/kg of A-1 twenty minutes prior to injection with strychnine protected the mice from strychnine-induced convulsions to the same extent as phenobarbitone (phenobarbital).
Type:
Grant
Filed:
September 27, 2018
Date of Patent:
May 28, 2019
Assignee:
King Saud University
Inventors:
Mutasim Ibrahim Khalil, Mustafa Abdalla Mohamed Salih, Ali Ahmed Mustafa Ali
Abstract: This invention is directed to substituted acylanilide compounds and uses thereof in treating muscular dystrophies such as Duchenne muscular dystrophy and Becker muscular dystrophy and in improving or preserving lung function and cardiac function in a subject suffering from Duchenne muscular dystrophy.
Type:
Grant
Filed:
October 18, 2017
Date of Patent:
May 28, 2019
Assignee:
UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
Inventors:
James T. Dalton, Thamarai Ponnusamy, Ramesh Narayanan
Abstract: The present invention relates to methods for treating cell proliferation disorders comprising: (1) administering to the subject at least one activatable pharmaceutical agent that is capable of activation by a simultaneous two photon absorption event and of effecting a predetermined cellular change when activated; (2) administering at least one plasmonics-active agent to the subject, and (3) applying an initiation energy from an initiation energy source to the subject, wherein the plasmonics-active agent enhances or modifies the applied initiation energy, such that the enhanced or modified initiation energy activates the activatable pharmaceutical agent by the simultaneous two photon absorption event in situ, thus causing the predetermined cellular change to occur, wherein said predetermined cellular change treats the cell proliferation related disorder; and the use of plasmonics enhanced photospectral therapy (PEPST) and exiton-plasmon enhanced phototherapy (EPEP) in the treatment of various cell prolifer
Abstract: The low cement content strain-hardening cementitious composite is cement with a natural pozzolan replacing a significant portion of the Portland cement therein. The strain-hardening cementitious composite includes a mixture of cement, fly ash, sand, a polycarboxylic ether-based superplasticizer, and reinforcing polyvinyl alcohol fibers. The mixture is formed with a low content of Portland cement (6-12 wt %) and with ground scoria as the natural pozzolan (5-20%). The sand forms at least 22 wt % of the strain-hardening cementitious composite and is preferably in the form of sieved dune sand, having a silicon dioxide concentration of between approximately 80 and 90 wt %, and a feldspar concentration of between approximately 10 and 20 wt %. The dune sand is sieved such that the sand grains have a median diameter of less than or equal to approximately 300 ?m, and preferably have a median diameter of approximately 200 ?m.
Abstract: A method of removing organic carbon in biological wastewater treatment includes the steps of: (a) oxidizing organic carbon to carbon dioxide with elemental sulfur as an electron carrier, and reducing the elemental sulfur to sulfide; (b) oxidizing the sulfide to elemental sulfur by recycled nitrate through controlling one or more of a recycling ratio to maintain an oxidation reduction potential (ORP) within the range of ?360 mv to ?420 mv, using an auto ORP controller; (c) recycling the elemental sulfur formed during oxidation of the sulfide back to the oxidation of the organic carbon; and (d) oxidizing ammonium to nitrate then partially recycled back for sulfide oxidation.
Type:
Grant
Filed:
January 12, 2016
Date of Patent:
May 28, 2019
Assignee:
THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
Inventors:
Guanghao Chen, Feng Jiang, Ho Kwong Chui
Abstract: A method and devices are described, in which a transformable fiber at a first crystal structure is shaped from its pre-determined configuration into a new shaped configuration. The new shaped configuration of the transformable fiber is inserted into a cavity of a heat and fire protective item. The new shaped configuration of the transformable fiber is heated to above its transformation temperature to a second crystal structure. The heating transforms the new shaped configuration to its pre-determined configuration, wherein the pre-determined configuration forms an air pocket within the heat and fire protective item. The transformable fiber is cooled below its transformation temperature to revert the transformable fiber back to the new shaped configuration at the first crystal structure.
Abstract: An analog-digital converter may include: an analog-digital converter comprising: a ramp signal selection unit suitable for receiving ramp signals having different offsets, and sequentially selecting one of the ramp signals according to a preset order; a comparison unit suitable for comparing the magnitudes of the selected ramp signal with a pixel signal, and outputting a comparison signal according to the comparison result; and a counting unit suitable for counting the number of clocks of a clock signal until the comparison signal transitions, and outputting a count signal based on the count when the comparison signal transitions.
Type:
Grant
Filed:
May 25, 2017
Date of Patent:
May 28, 2019
Assignees:
SK hynix Inc., Industry-University Cooperation Foundation Hanyang University
Inventors:
Sang Dong Yoo, Min Kyu Kim, Jun Bo Shim
Abstract: In one aspect, kits for constructing an apparatus are described herein which, in some embodiments, can demonstrate desirable modularity, adjustability, and reconfigurability. A kit for constructing an apparatus described herein comprises a plurality of modular blocks and fastening pins and coupling pins for connecting the modular blocks to one another. A modular block comprises a first face having one or more first apertures for receiving fastening pins and an adjacent second face having one or more second apertures for receiving coupling pins. A fastening pin comprises a sidewall aperture for receiving a coupling pin.
Type:
Grant
Filed:
August 31, 2015
Date of Patent:
May 28, 2019
Assignee:
THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE
Abstract: Disclosed are methods and systems for subnanosecond rise time high voltage (HV) electric pulse delivery to biological loads. The system includes an imaging device and monitoring apparatus used for bio-photonic studies of pulse induced intracellular effects. The system further features a custom fabricated microscope slide having micro-machined electrodes. A printed circuit board to interface the pulse generator to the micro-machined glass slide having the cell solution is disclosed. An low-parasitic electronic setup to interface with avalanche transistor-switched pulse generation system is also disclosed. The pc-board and the slide are configured to match the output impedance of the pulse generator which minimizes reflection back into the pulse generator, and minimizes distortion of the pulse shape and pulse parameters. The pc-board further includes a high bandwidth voltage divider for real-time monitoring of pulses delivered to the cell solutions.
Abstract: The present invention relates to the production of cell cultures and tissues from undifferentiated pluripotent stem cells using three-dimensional biomimetic materials. The resultant cell cultures or tissues can be used in any of a number of protocols including testing chemicals, compounds, and drugs. Further, the methods and compositions of the present invention further provide viable cell sources and novel cell delivery platforms that allow for replacement of diseased tissue and engraftment of new cardiomyocytes from a readily available in vitro source. The present invention includes novel methods required for the successful production of cell cultures and tissues, systems and components used for the same, and methods of using the resultant cell and tissue compositions.
Type:
Grant
Filed:
January 20, 2017
Date of Patent:
May 28, 2019
Assignee:
Auburn University
Inventors:
Elizabeth A. Lipke, Petra Kerscher, Alexander J. Hodge
Abstract: Embodiments of the present disclosure provide for methods of making quantum dots (QDs) (passivated or unpassivated) using a continuous flow process, systems for making QDs using a continuous flow process, and the like. In one or more embodiments, the QDs produced using embodiments of the present disclosure can be used in solar photovoltaic cells, bio-imaging, IR emitters, or LEDs.
Type:
Grant
Filed:
October 3, 2014
Date of Patent:
May 28, 2019
Assignee:
KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
Inventors:
Osman M. Bakr, Jun Pan, Ala'a El-Ballouli, Kristian Rahbek Knudsen, Ahmed L. Abdelhady
Abstract: An image is reconstructed based upon a filtered backprojection (FBP) technique using a reconstruction filter which is customized or shaped by parameters including a weight value that is determined for weighing projection data according to a predetermined noise model. The weight value is determined based upon rays or views in the projection data. A regularization term is also combined with the noise-weighted FBP.
Type:
Grant
Filed:
July 30, 2012
Date of Patent:
May 28, 2019
Assignees:
TOSHIBA MEDICAL SYSTEMS CORPORATION, UNIVERSITY OF UTAH REASEARCH FOUNDATION
Abstract: There is set forth herein a system including a camera device. In one embodiment the system is operative to perform image processing for detection of an event involving a human subject. There is set forth herein in one embodiment, a camera equipped system employed for fall detection.
Abstract: A method of operating a transmitting apparatus in a multimedia system is provided. The method includes transmitting a data unit of a multimedia service including event information related to an event, wherein the event includes notification to an application, the notification indicating that an action is to be taken.
Type:
Grant
Filed:
June 23, 2016
Date of Patent:
May 28, 2019
Assignees:
Samsung Electronics Co., Ltd., KYONGGI UNIVERSITY INDUSTRY & ACADEMIA COOPERATION FOUNDATION
Abstract: A lactic acid bacterium-containing composition including a lactic acid bacterium having a human papillomavirus (HPV) E7 protein-derived polypeptide on a surface thereof, wherein the HPV E7 protein-derived polypeptide is included in an amount of 0.03 ?g to 1.0 ?g per 1×108 lactic acid bacteria; a therapeutic oral pharmaceutical composition for at least one of an HPV infectious disease and an HPV-associated tumor which includes the lactic acid bacterium-containing composition; and a mucosal immunity-inducing agent which includes the lactic acid bacterium-containing composition.
Type:
Grant
Filed:
January 28, 2016
Date of Patent:
May 28, 2019
Assignees:
The University of Tokyo, Japan Health Sciences Foundation
Abstract: A method evaluates the mobility of a polymer composition in a high-temperature region of 150° C. or above. The method for evaluating a physical property of a polymer composition, the method comprising the steps of: obtaining a thin film sample which is formed on a substrate and which comprises: a fluorescent probe including a fluorescent rare earth complex having a melting point of 200° C. or higher; and a target polymer composition; and obtaining a relationship between a temperature and a fluorescent characteristic of the thin film.
Type:
Grant
Filed:
May 8, 2015
Date of Patent:
May 28, 2019
Assignees:
Kyushu University, Fuji Electric Co., Ltd.
Abstract: Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. This neural fulcrum zone corresponds to a combination of stimulation parameters at which autonomic engagement is achieved, while the tachycardia-inducing stimulation effects are offset by the bradycardia-inducing effects, thereby minimizing side effects such as significant heart rate changes while providing a therapeutic level of stimulation.
Type:
Grant
Filed:
May 19, 2017
Date of Patent:
May 28, 2019
Assignees:
LivaNova USA, Inc., East Tennessee State University
Inventors:
Bruce H. KenKnight, Jeffrey L. Ardell, Imad Libbus, Badri Amurthur